stockrow
Friday 6 November 2026
Export MDXHF’s income statement to Excel — free account
MedX Health Corp.
MDXHF Healthcare Diagnostics & Research
MedX Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $338,700.00, down 5.23% from fiscal 2024.
- Revenue
- +33.6%
- EPS
- −6.06%
- Free cash flow
- +41.6%
- Total debt
- −8.75%
Quarter to June 2026, against a year earlier
0.03
0.00
0.00%
Follow MDXHF
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 2 | 2 | 3 |
+8 more TTM periods Free account |
| 63.71% | 63.45% | 68.26% | 54.70% | ||
| (840.71%) | (867.29%) | (784.32%) | (487.89%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
68.86% | 73.83% | 66.31% | 61.68% | |
Average Days of Receivables |
21.86 | 66.93 | 97.93 | 359.84 | |
Free Cash Flow per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Free Cash Flow |
(2.71) | (3.91) | (3.77) | (3.59) | |
Capital Expenditures |
— | (0.99) | (1.10) | (1.29) | |
| Other line items | |||||
Cash ROIC |
49.99% | 83.59% | 65.71% | 83.33% | |
Accounts Receivable Turnover |
2.52 | 2.56 | 2.22 | 1.36 | |
Accounts Payable Turnover |
0.23 | 0.22 | 0.22 | 0.13 | |
Inventory Turnover |
2.14 | 2.17 | 1.85 | 0.85 | |
Average Days of Payables |
1,558.85 | 1,656.79 | 1,699.98 | 2,984.39 | |
Days of Inventory on Hand |
82.09 | 93.85 | 130.14 | 422.37 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.14 | |
Research and Development Expense of Revenue |
107.68% | 95.81% | 105.64% | 96.80% | |
Selling, General and Administrative Expense of Revenue |
643.81% | 639.69% | 789.58% | 570.55% | |
Share Based Compensation of Revenue |
95.56% | 52.33% | 183.15% | 135.77% | |
Interest Coverage |
(2.57) | (2.40) | (2.44) | (1.69) | |
Operating CF/Net income |
0.60 | 0.68 | 0.59 | 0.61 | |
Depreciation/Fixed assets |
0.23 | 0.20 | 0.18 | 0.15 | |
Capex/Depreciation |
0.00 | (24.40) | (29.85) | (37.54) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 2.53 | 3.26 | 3.45 |
Columns are period end dates · fundamentals updated 26 Oct 2026